QL
CYTK icon

Quarry LP’s Cytokinetics CYTK Stock Holding History

Quarry LP’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-147
Closed -$9.34K – 1621
2025
Q4 		$9.34K Sell
147
-402
-73% -$25K ﹤0.01% 1438
2025
Q3 		$30.2K Buy
+549
New +$22.6K 0.01% 1153
2025
Q1 		– Sell
-800
Closed -$37.6K – 1706
2024
Q4 		$37.6K Sell
800
-2,200
-73% -$114K 0.01% 903
2024
Q3 		$158K Buy
3,000
+1,000
+50% +$55.7K 0.04% 294
2024
Q2 		$108K Buy
2,000
+1,400
+233% +$84.5K 0.03% 315
2024
Q1 		$42.1K Buy
+600
New +$46.4K 0.01% 543

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quarry LP's CYTK Position: Q1 2026 in Review

Quarry LP sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 147 shares — an estimated $9.34K sold.

Quarry LP first reported a position in CYTK in Q1 2024 and held it in 6 quarters. The position peaked at $158K in Q3 2024. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Quarry LP reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
  • Quarry LP sold 147 Cytokinetics shares in Q1 2026, an estimated $9.34K.
  • Quarry LP first reported a position in Cytokinetics in Q1 2024 and held it in 6 quarters.
  • Quarry LP's Cytokinetics position peaked at $158K in Q3 2024.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.